Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Daiichi Sankyo
Citi
Baxter
McKesson
Deloitte
Chinese Patent Office
Cipla
Colorcon

Generated: June 19, 2018

DrugPatentWatch Database Preview

TRIAMCINOLONE DIACETATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Triamcinolone Diacetate, and what generic alternatives are available?

Triamcinolone Diacetate is a drug marketed by Akorn and Watson Labs and is included in four NDAs.

The generic ingredient in TRIAMCINOLONE DIACETATE is triamcinolone diacetate. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone diacetate profile page.
Summary for TRIAMCINOLONE DIACETATE
Drug patent expirations by year for TRIAMCINOLONE DIACETATE
Synonyms for TRIAMCINOLONE DIACETATE
(11.beta.,16.alpha.)-16,21-Bis(acetyloxy)-9-fluoro-11,17-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,21-Bis(acetyloxy)-9-fluoro-11,17-dihydroxypregna-1,4-diene-3,20-dione
[2-(16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] acetate
[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxo-ethyl] acetate
[2-[(8S,9R,10S,11S,13S,14S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
[2-[(9R,10S,11S,13S,16R,17S)-16-acetyloxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
056T462
1.6alpha.-Hydroxy-9.alpha.-fluoroprednisolone diacetate
16-(Acetyloxy)-9-fluoro-11,17-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate, (11.beta.,16.alpha.)- #
16a,21-diacetoxy-9a-fluoro-11b,17a-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha-Hydroxy-9alpha-fluoroprednisolone diacetate
16alpha,21-Diacetoxy-9alpha-fluoro-11beta,17alpha-dihydroxy-1,4-pregnadiene-3,20-dione
2-((8S,9R,10S,11S,13S,14S,16R,17S)-16-Acetoxy-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
2-[(1R,2S,10S,11S,13R,14S,15S,17S)-13-(ACETYLOXY)-1-FLUORO-14,17-DIHYDROXY-2,15-DIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL]-2-OXOETHYL ACETATE
357RP
67-78-7
9-.alpha.-Fluoro-16-.alpha.-hydroxyprednisolone diacetate
9-alpha-Fluoro-16-alpha-hydroxyprednisolone diacetate
9-Fluoro-11-.beta.,16-.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate
9-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate
9-fluoro-11,17-dihydroxy-3,20-dioxopregna-1,4-diene-16,21-diyl diacetate
9-Fluoro-11b,16a,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,21-diacetate
9a-Fluoro-16a-hydroxyprednisolone 16,21-diacetate
9alpha-Fluoro-11beta,16alpha,17alpha,21-tetrahydroxy-1,4-pregnadiene-3,20-dione 16,21-diacetate
9alpha-Fluoro-16alpha-hydroxyprednisolone 16,21-diacetate
A73MM2Q32P
AB00052115_02
AC-3522
AC1L1M1O
AC1LBO3D
AC1NWAQY
AC1Q62MR
AC1Q62P4
AK386608
AKOS025402044
AN-12860
API0004485
Aristocort diacetate
Aristocort diacetate forte
Aristocort Forte
Aristocort Forte Parenteral
Aristocort Parenterals
Aristocort syrup
BRD-A30717181-001-01-9
BSPBio_002922
C08184
CAS-67-78-7
CCG-40085
Cenacort
CHEBI:9669
CHEMBL1200449
CINO-40
D00984
delta1,9alpha-Fluoro-16alpha-hydroxyhydrocortisone diacetate
delta11,16alpha-Hydroxy-9alpha-fluorohydrocortisone diacetate
DivK1c_000549
DSSTox_CID_28639
DSSTox_GSID_48713
DSSTox_RID_82909
DTXSID0048713
EINECS 200-669-0
HMS1921G11
HMS2092O15
HMS501L11
IDI1_000549
KBio1_000549
KBio2_001025
KBio2_003593
KBio2_006161
KBio3_002142
KBioGR_000829
KBioSS_001025
Kenacort Diacetate Syrup
Kenacourt
LS-1569
MCULE-5259140954
MFCD00056462
MolPort-002-529-443
NCGC00159320-02
NCGC00159320-03
NCGC00159320-04
NCGC00178390-01
NINDS_000549
NSC-757356
NSC757356
Pharmakon1600-01500588
PL009586
Polcartolone
Pregna-1,4-diene-2,20-dione, 9-fluoro-11-.beta.,16-.alpha.,17,21-tetrahydroxy-, 16,21-diacetate
Pregna-1,4-diene-2,20-dione, 9-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-, 16,21-diacetate
Pregna-1,4-diene-3,20-dione, 16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.,16.alpha.)-
Pregna-1,4-diene-3,20-dione, 16,21-bis(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11beta,16alpha)-
Q-201856
SBI-0051543.P002
SCHEMBL12549
SPBio_000958
Spectrum_000545
SPECTRUM1500588
Spectrum2_000959
Spectrum3_001371
Spectrum4_000365
Spectrum5_000994
SR-05000001731
SR-05000001731-1
STOCK1N-57352
TAC-D
Tedarol
Tox21_113119
Tox21_113119_1
Tracilon
Triamcinolone 16-alpha,21-di(acetate)
Triamcinolone 16,21-diacetate
Triamcinolone diacetate (JAN/USP)
TRIAMCINOLONE DIACETATE (SEE TRIAMCINOLONE ACETONIDE (76-25-5))
Triamcinolone diacetate [JAN]
Triamcinolone diacetate, United States Pharmacopeia (USP) Reference Standard
Triamcinolonediacetate
Triamolone 40
UNII-A73MM2Q32P
XGMPVBXKDAHORN-UHFFFAOYSA-N
ZINC3875441

US Patents and Regulatory Information for TRIAMCINOLONE DIACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 085122-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 085529-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 086394-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs TRIAMCINOLONE DIACETATE triamcinolone diacetate INJECTABLE;INJECTION 084072-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Merck
AstraZeneca
Moodys
Harvard Business School
Argus Health
Accenture
Teva
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.